PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

NCT02991482 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

144

Enrollment

NETWORK

Sponsor class

Conditions

Pleural Mesothelioma Malignant Advanced

Interventions

DRUG: Pembrolizumab
DRUG: Gemcitabine
DRUG: Vinorelbine

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]
[object Object]